Roche Molecular Systems
This article was originally published in The Gray Sheet
Executive SummaryFiles export request application with FDA for its Amplicor Hepatitis C virus (HCV) PCR test, according to a Dec. 15 Federal Register notice. Roche is asking for approval to export the test, which uses nucleic acid amplification and nucleic acid hybridization to detect HCV in human plasma and serum, to Australia, Belgium, Canada, Denmark, Germany, Ireland, Italy, Japan, Luxembourg, The Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the United Kingdom
You may also be interested in...ï»¿
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDAâ€™s â€˜Project Renewalâ€™ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.